Lactoferrin in the reduction of pain

Details Lactoferrin in the reduction of pain Lactoferrin in the reduction of pain

2003-12-11

2008-01-29

Kam, Chih-Min (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S008100, C530S350000, C530S395000, C530S400000, C424S009100, C424S085100

Reexamination Certificate

active

07323443

ABSTRACT:
The present invention relates to methods of using lactoferrin (LF) to reduce pain in conditions associated with severe or intractable pain by administering a composition of lactoferrin either alone or in combination with other therapy for pain.

REFERENCES:
patent: 5561109 (1996-10-01), Mita et al.
patent: 5576299 (1996-11-01), Ando et al.
patent: 5712247 (1998-01-01), Wu et al.
patent: 5919913 (1999-07-01), Nuyens et al.
patent: 6066469 (2000-05-01), Kruzel et al.
patent: 6080559 (2000-06-01), Conneely et al.
patent: 6100054 (2000-08-01), Conneely et al.
patent: 6228614 (2001-05-01), Conneely et al.
patent: 6277817 (2001-08-01), Kruzel et al.
patent: 6333311 (2001-12-01), Nuijens et al.
patent: 6455687 (2002-09-01), Kruzel et al.
patent: 2002/0064524 (2002-05-01), Cevc
patent: 2002/0107283 (2002-08-01), Codd et al.
patent: 2003/0039651 (2003-02-01), Olmarker
patent: 2003/0077641 (2003-04-01), Laskowitz et al.
patent: 2003/0096763 (2003-05-01), Kruzel et al.
patent: 2004/0009895 (2004-01-01), Varadhachary et al.
patent: 2004/0018190 (2004-01-01), Ando et al.
patent: 2005/0019342 (2005-01-01), Varadhachary et al.
patent: WO-98/33509 (1998-08-01), None
patent: WO 00/01730 (2000-01-01), None
patent: WO-200203910 (2002-01-01), None
patent: WO-0280897 (2002-10-01), None
patent: WO-03061688 (2003-07-01), None
Teschemacher, Hansjorg “Lactoferrin elicits opioid-mediated antinociception without development of toleence: central nNOS-1 set off duty?” American Journal Physiol. Regul Integr Comp Physiol 285, R302-R305.
Hayashida et al, “Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord,” Am J Physiol Regul Integr Comp Physiol 285, 2003; R306-R312.
Hayashida et al, “Novel function of bovine milk-derived lactoferrin on antinociception mediated by M-opioid receptor in the rat spinal cord,” Brain research 965, 2003, pp. 239-245.
Baraniuk et al, “Hypertonic Saline Nasal Provocation Stimulates Nociceptive Nerves, Substances P Release, and Glandular Mucous Exocytosis in Normal Humans,” Am J Respir Crit care Med vol. 160, 1999, pp. 655-662.

Affiliated with

Also associated with

Rating

Lactoferrin in the reduction of pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lactoferrin in the reduction of pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactoferrin in the reduction of pain will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3964312